475272-55-0 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
(S)-1-Boc-3-benzylpiperazine is used as a building block for the synthesis of various pharmaceuticals and agrochemicals, due to its versatile chemical structure and reactivity.
Used in Antiviral and Anticancer Research:
(S)-1-Boc-3-benzylpiperazine is used as a precursor in the synthesis of biologically active compounds with antiviral and anticancer properties, contributing to the development of new therapeutic agents.
Used in Central Nervous System Stimulation:
(S)-1-Boc-3-benzylpiperazine is studied for its potential as a central nervous system stimulant, which could have applications in the treatment of certain neurological conditions or cognitive enhancement.
Used in Neuroprotective Applications:
(S)-1-Boc-3-benzylpiperazine has shown promise in neuroprotective applications, potentially offering protection to neurons and contributing to the development of treatments for neurodegenerative diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 475272-55-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,5,2,7 and 2 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 475272-55:
(8*4)+(7*7)+(6*5)+(5*2)+(4*7)+(3*2)+(2*5)+(1*5)=170
170 % 10 = 0
So 475272-55-0 is a valid CAS Registry Number.
InChI:InChI=1/C16H24N2O2/c1-16(2,3)20-15(19)18-10-9-17-14(12-18)11-13-7-5-4-6-8-13/h4-8,14,17H,9-12H2,1-3H3/t14-/m0/s1
475272-55-0Relevant academic research and scientific papers
Expedite protocol for construction of chiral regioselectively N-protected monosubstituted piperazine, 1,4-diazepane, and 1,4-diazocane building blocks
Crestey, Francois,Witt, Matthias,Jaroszewski, Jerzy W.,Franzyk, Henrik
supporting information; experimental part, p. 5652 - 5655 (2009/12/08)
(Chemical Equation Presented) This paper describes the first study of solution-phase synthesis of chiral monosubstituted piperazine building blocks from nosylamide-activated aziridines. The protocol, involving aminolysis of the starting aziridines with ω-amino alcohols and subsequent Fukuyama-Mitsunobu cyclization, offers the advantage of mild conditions as well as short reaction times, and it leads to optically pure N-Boc- or N-Ns-protected piperazines. This four-step sequence, requiring only a single final chromatographic purification, was extended to include novel diazepane and diazocane derivatives.
